Hadebe, BawinileHarry, LerwineGabela, LeratoMasikane, SiphelelePatel, MaryamZwane, SizwePillay, VenesenBipath, PreshaCebekhulu, NonhlanhlaNyakale, Nozipho E.Ramdass, PrathimaMsimang, MpumeleloAldous, ColleenSathekge, Mike MachabaVorster, Mariza2024-12-132024-12-132024-06Hadebe, B.; Harry, L.; Gabela, L.; Masikane, S.; Patel, M.; Zwane, S.; Pillay, V.; Bipath, P.; Cebekhulu, N.; Nyakale, N.; et al. Chemokine Receptor-4 Targeted PET/CT Imaging with 68Ga-Pentixafor in Head and Neck Cancer—A Comparison with 18F-FDG and CXCR4 Immunohistochemistry. Diagnostics 2024, 14, 1375. https://doi.org/10.3390/diagnostics14131375.2075-4418 (online)10.3390/diagnostics14131375http://hdl.handle.net/2263/100007DATA AVAILABITY STATEMENT: The raw data supporting the conclusions of this article will be made available by the authors on request.Please read abstract in article.en© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).PentixaforSDG-03: Good health and well-beingSDG-09: Industry, innovation and infrastructureHead and neck squamous cell carcinoma (HNSCC)Positron emission tomography/computed tomography (PET/CT)Human immunodeficiency virus (HIV)Chemokine receptor 4 (CXCR4)Article